| Date | Time | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|
| 27/05/2022 | 08:20 to 10:50 | Myelodysplastic syndromes (MDS) | 09:20 to 09:40 | My low-risk MDS patient with ring sideroblasts is losing response to erythropoietin. What to do? | Speaker |
| 27/05/2022 | 08:20 to 10:50 | Myelodysplastic syndromes (MDS) | 10:20 to 10:50 | Q&A | Discussant |